Michael Dunne

(Dr. Michael Dunne M.D.)

Currently holds a position at Iterum Therapeutics PLC

Positions
Position Company Period
Chief Scientific Officer Iterum Therapeutics PLC Nov. 1, 2015 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2023-12-27 2023-12-22
B Purchase
25,000 +28.2%
1.40
35,000 USD 		25,000 +28.2% 1.40 35,000 USD
2023-12-19 2023-12-18
B Purchase
10,000 +12.7%
1.84
18,442 USD 		10,000 +12.7% 1.84 18,442 USD
2022-09-09 2022-09-07
B Purchase
10,000 +39.1%
2.22
22,200 USD 		10,000 +39.1% 2.22 22,200 USD
2021-01-27 2021-01-26
S Sale
33,143 -11.4%
1.73
57,337 USD 		33,143 -11.4% 1.73 57,337 USD
2020-10-28 2020-10-27
B Purchase
61,540
0.00
0 USD 		61,540 0.00 0 USD